Press Releases | Medtronic

Month Year

Email alerts

Jan 10, 2018

FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity

SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients

DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new clinician programmer for use with the SynchroMed(TM)II Intrathecal...
Jan 9, 2018

Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming

As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment

DUBLIN - January 9, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable...
Dec 29, 2017

Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

DUBLIN - December 29, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday,...
Dec 19, 2017

Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region

Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company

DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic's Asia Pacific (APAC) Region, has been named...
Dec 8, 2017

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2018

DUBLIN - December 8, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 third quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...
Dec 1, 2017

Medtronic EVP & RTG President Geoff Martha to Speak at Citi Global Healthcare Conference

DUBLIN - December 1, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Citi 2017 Global Healthcare Conference on Wednesday,...
Nov 27, 2017

Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract

Medtronic Care Management Services Delivers on Its Commitment to Serve Veteran Patients with Expanded Suite of Telehealth Solutions

DUBLIN - November 27, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business commenced launch of new telehealth solutions in support of its national...
Nov 21, 2017

Medtronic Reports Second Quarter Financial Results

Revenue of $7.1 Billion; GAAP Diluted EPS of $1.48; Non-GAAP Diluted EPS of $1.07

DUBLIN - November 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2018, which ended October 27, 2017. The company reported second...
Nov 20, 2017

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers

Azure(TM) with BlueSync(TM) Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring

DUBLIN - November 20, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with...
Nov 13, 2017

Medtronic to Present New Clinical Data on Vascular Interventions and Key Symposia at VEITHsymposium 2017

DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular...

Show per page